Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$230M Buy
653,500
+6,300
+1% +$2.25M 0.03% 352
2025
Q4
$212M Sell
647,200
-74,000
-10% -$23.5M 0.03% 331
2025
Q3
$204M Buy
721,200
+80,800
+13% +$23.4M 0.03% 351
2025
Q2
$179M Buy
640,400
+438,300
+217% +$124M 0.04% 312
2025
Q1
$63M Sell
202,100
-123,900
-38% -$36.6M 0.02% 545
2024
Q4
$85M Sell
326,000
-372,800
-53% -$111M 0.02% 486
2024
Q3
$225M Buy
698,800
+498,200
+248% +$163M 0.05% 203
2024
Q2
$62.7M Sell
200,600
-80,300
-29% -$23.6M 0.01% 585
2024
Q1
$79.9M Buy
280,900
+116,400
+71% +$34.1M 0.02% 438
2023
Q4
$47.4M Sell
164,500
-3,900
-2% -$1.06M 0.01% 703
2023
Q3
$45.3M Buy
168,400
+56,500
+50% +$14.1M 0.01% 600
2023
Q2
$24.8M Buy
111,900
+20,000
+22% +$4.64M 0.01% 1022
2023
Q1
$22.2M Sell
91,900
-21,400
-19% -$5.25M 0.01% 924
2022
Q4
$29.8M Sell
113,300
-380,100
-77% -$102M 0.01% 760
2022
Q3
$111M Sell
493,400
-1,281,200
-72% -$311M 0.05% 254
2022
Q2
$432M Buy
1,774,600
+38,900
+2% +$9.53M 0.18% 54
2022
Q1
$420M Buy
1,735,700
+1,557,900
+876% +$358M 0.14% 73
2021
Q4
$40M Sell
177,800
-14,600
-8% -$3.08M 0.01% 760
2021
Q3
$40.9M Buy
192,400
+109,200
+131% +$25.1M 0.01% 692
2021
Q2
$20.3M Sell
83,200
-6,500
-7% -$1.6M 0.01% 1066
2021
Q1
$22.3M Sell
89,700
-12,900
-13% -$3.08M 0.01% 891
2020
Q4
$23.6M Sell
102,600
-17,100
-14% -$3.94M 0.01% 775
2020
Q3
$30.4M Buy
119,700
+49,400
+70% +$12.2M 0.02% 573
2020
Q2
$16.6M Buy
70,300
+3,800
+6% +$867K 0.01% 854
2020
Q1
$13.5M Sell
66,500
-105,100
-61% -$23M 0.01% 616
2019
Q4
$41.4M Buy
171,600
+116,700
+213% +$25.7M 0.06% 210
2019
Q3
$10.6M Sell
54,900
-300
-0.5% -$57.6K 0.02% 570
2019
Q2
$10.2M Sell
55,200
-20,100
-27% -$3.6M 0.02% 622
2019
Q1
$14.3M Buy
75,300
+30,500
+68% +$5.82M 0.02% 533
2018
Q4
$8.72M Buy
44,800
+1,100
+3% +$215K 0.02% 649
2018
Q3
$9.06M Buy
43,700
+11,200
+34% +$2.21M 0.02% 668
2018
Q2
$6M Sell
32,500
-4,700
-13% -$831K 0.01% 907
2018
Q1
$6.34M Sell
37,200
-10,300
-22% -$1.89M 0.02% 806
2017
Q4
$8.26M Sell
47,500
-118,200
-71% -$20.9M 0.02% 580
2017
Q3
$30.9M Buy
165,700
+112,500
+211% +$19.9M 0.1% 186
2017
Q2
$9.16M Sell
53,200
-16,300
-23% -$2.65M 0.03% 495
2017
Q1
$11.4M Sell
69,500
-28,600
-29% -$4.75M 0.05% 338
2016
Q4
$14.3M Buy
98,100
+66,900
+214% +$10.1M 0.06% 243
2016
Q3
$5.2M Sell
31,200
-41,900
-57% -$7.09M 0.02% 578
2016
Q2
$11.1M Buy
73,100
+19,600
+37% +$3.05M 0.06% 300
2016
Q1
$8.02M Buy
53,500
+4,100
+8% +$609K 0.05% 376
2015
Q4
$8.02M Buy
49,400
+29,100
+143% +$4.57M 0.05% 340
2015
Q3
$2.81M Sell
20,300
-24,600
-55% -$3.88M 0.02% 742
2015
Q2
$6.89M Buy
44,900
+38,300
+580% +$6.14M 0.04% 340
2015
Q1
$1.05M Sell
6,600
-200
-3% -$31.5K 0.01% 1329
2014
Q4
$1.08M Buy
+6,800
New +$1.06M 0.01% 975

Other funds holding AMGN

Jane Street's AMGN Position: Q1 2026 in Review

Jane Street increased its Amgen (AMGN) stake by 249% in Q1 2026, buying an estimated $28.2M and bringing the position to 110,665 shares worth $38.9M. The position accounts for 0.01% of the portfolio, ranked #1225.

Jane Street first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $133M in Q3 2023. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Jane Street held 110,665 shares of Amgen worth $38.9M as of Q1 2026.
  • Jane Street bought 78,976 Amgen shares in Q1 2026, an estimated $28.2M.
  • Amgen made up 0.01% of Jane Street's portfolio in Q1 2026, its #1225 holding.
  • Jane Street first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • Jane Street's Amgen position peaked at $133M in Q3 2023.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.